Herein, we purposed to determine the prognostic worthiness of systemic immune-inflammation index–albumin-bilirubin scores in patients receiving transarterial chemoembolization for unresectable hepatocellular carcinoma. This evidence concerns the gene ALB and hepatocellular carcinoma.